02.03.2018
- Sanofi has received all the necessary regulatory approvals for its planned €3.9 billion takeover of Belgian biotech Ablynx. The deal was announced on Jan. 29. The next step is to...
30.01.2018
- Sanofi is to acquire Belgium biopharma Ablynx in a deal valued at around €3.9 billion. The announcement comes just days after the French drugmaker announced its intention to buy US...
04.08.2017
- French drugmaker Sanofi has signed a research and licensing deal with Belgian biopharmaceutical company Ablynx, initially focusing on the development and commercialization of...
04.10.2012
- From its base in a business park outside the city of Ghent, Belgium's biotech industry is attracting a global following, benefiting from years of patient investment, promising...
